![Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways](https://www.spandidos-publications.com/article_images/mmr/25/2/mmr-25-02-12575-g06.jpg)
Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways
![ZOMETA (zoledronic acid) for Hypercalcemia of Malignancy and Bone Metastases - Cancer Therapy Advisor ZOMETA (zoledronic acid) for Hypercalcemia of Malignancy and Bone Metastases - Cancer Therapy Advisor](https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2018/12/slide12111_1053447.jpg)
ZOMETA (zoledronic acid) for Hypercalcemia of Malignancy and Bone Metastases - Cancer Therapy Advisor
![Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram](https://www.researchgate.net/publication/230850646/figure/fig1/AS:202882147196929@1425382281783/Mechanism-of-action-of-denosumab-compared-to-zoledronic-acid-Notes-RANKL-is-secreted-by.png)
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
![Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article](https://assets.cureus.com/uploads/figure/file/90324/lightbox_56873fb01c7f11ea967fe109aa9b495a-Figure-2_formatted_V1-PME.png)
Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article
![Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram](https://www.researchgate.net/publication/324912322/figure/fig4/AS:865472643862537@1583356166698/Mechanism-of-action-of-abiraterone-acetate-enzalutamide-radium-223-dichloride_Q640.jpg)
Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram
![Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram](https://www.researchgate.net/profile/Pilar-Garrido-2/publication/280998264/figure/fig3/AS:284610790477826@1444867908479/figure-fig3_Q320.jpg)
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
![Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00198-007-0540-8/MediaObjects/198_2007_540_Fig8_HTML.gif)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink
![Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy | ACS Biomaterials Science & Engineering Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy | ACS Biomaterials Science & Engineering](https://pubs.acs.org/cms/10.1021/acsbiomaterials.9b00362/asset/images/large/ab-2019-00362z_0009.jpeg)
Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy | ACS Biomaterials Science & Engineering
![Cancers | Free Full-Text | Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer Cancers | Free Full-Text | Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer](https://pub.mdpi-res.com/cancers/cancers-12-00104/article_deploy/html/images/cancers-12-00104-g001.png?1581005235)
Cancers | Free Full-Text | Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer
![Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1f5b0bc0-32e9-4e7e-a668-784d55e0870f/ijcp_12022_f2.gif)
Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library
![Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug | Scientific Reports Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-05553-0/MediaObjects/41598_2017_5553_Fig1_HTML.jpg)
Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug | Scientific Reports
![Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma | Bentham Science Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/cdt/19/5/001.jpg)
Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma | Bentham Science
![Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07568-9/MediaObjects/12885_2020_7568_Fig3_HTML.png)
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text
![PDF] The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. | Semantic Scholar PDF] The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/02ae3788787adf6a230ad8aee9e0cf256fd0f00b/2-Figure1-1.png)
PDF] The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. | Semantic Scholar
![Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.0c10764/asset/images/large/nn0c10764_0001.jpeg)
Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano
![Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2212137420300725-gr1.jpg)
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
![Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram](https://www.researchgate.net/profile/Andrew-Yee-7/publication/230850646/figure/fig1/AS:202882147196929@1425382281783/Mechanism-of-action-of-denosumab-compared-to-zoledronic-acid-Notes-RANKL-is-secreted-by_Q640.jpg)
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
![The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network - Annals of Oncology The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/193fffc9-ee92-40b4-bf45-765251811739/gr1.jpg)
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network - Annals of Oncology
![Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2212137420300725-gr2.jpg)
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
![Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review - Alegre - 2014 - European Journal of Haematology - Wiley Online Library Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review - Alegre - 2014 - European Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ffe8c2cb-a482-4e65-95db-70356dde0927/ejh12239-fig-0001-m.jpg)
Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review - Alegre - 2014 - European Journal of Haematology - Wiley Online Library
![Efficacy and safety of continued zoledronic acid every 4 weeks versus every 12 weeks in women with bone metastases from breast cancer Results of the OPTIMIZE-2 trial – OncoPrescribe Efficacy and safety of continued zoledronic acid every 4 weeks versus every 12 weeks in women with bone metastases from breast cancer Results of the OPTIMIZE-2 trial – OncoPrescribe](http://www.oncoprescribe.com/app/uploads/_1406171985.jpg)